DAVID LONARD to Histone-Lysine N-Methyltransferase
This is a "connection" page, showing publications DAVID LONARD has written about Histone-Lysine N-Methyltransferase.
Connection Strength
0.148
-
Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma. Nat Commun. 2021 02 15; 12(1):1022.
Score: 0.148
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.